FDA approves Ozempic to reduce risks from chronic kidney disease in diabetes patients
Ozempic’s Expanded Role: A Future Look at Diabetes and Kidney Disease Management The recent FDA approval for Ozempic to reduce risks associated with chronic kidney disease marks a significant shift in how we approach the treatment of Type 2 diabetes and related complications. With its proven efficacy in clinical trials, Ozempic is reshaping expectations and … Read more